Competing Endogenous RNA and Coexpression Network Analysis for Identification of Potential Biomarkers and Therapeutics in association with Metastasis Risk and Progression of Prostate Cancer

Figure 1

The workflow for systematic analysis of the characterization of lncRNAs, miRNAs, and mRNAs in the risk of metastasis and progression of prostate cancer, identifying new potential biomarkers, and therapeutic compound based on drug repositioning strategy.